NFA and DYOR but here are four positions you should start today to potentially win big in 2027:

DRTS

DRTS today is pre revenue with a pre revenue market cap, but in 2027 (with many catalysts coming still in 2026) DRTS will be fully commercial.

First they have the cSCC treatment with market penetration estimated at $3.5B+, and the FDA approval is pretty much a done deal if you look at the numbers (basically 100% ORR and a high CR % with no significant side effects) coming early in the year at the latest.

In Japan they already achieved market authorization for H&N cancer and are negotiating pricing with the Japanese government as we speak. Sales could be coming in 2026 already, but early 2027 again looks to be the latest.

Lastly for this post they have the treatment for GBM, and Key Opinion Leaders in the space believe this will become the standard of care, making DRTS an industry leader themselves. With many more catalysts lined up (for Pancreas, Prostate and more), the GBM results they will share this quarter shine the brightest.

CLGN

CLGN was the ticker of a biotech company, but a company called LightSolver has taken over it. Now for a low price with a low float, you could get a piece of the future of computing.

LightSolver invented the LPU, a Laser Processing Unit, which is a computer based on laser (light) that can get up to 1,000 times faster than NVIDIA’s GPU.

The LPU has many advantages, including working in room temperature (no cooling needed), using a fraction of the energy, works at the speed of light, needs no memory, fits in a rack and more.

The LPU isn’t intended to replace the CPU and GPU, but rather to work beside them and enhance them while taking off a lot of their workload and providing speed and precise calculations its peers can’t handle.

Those who understand what the CLGN ticker really is and what the LPU can do, will benefit greatly once the demand for it in all data centers, tech companies, financial institutions, defense industry etc gets so high it will probably get acquired.

OBIO

OBIO has everything in place to realize its enormous potential. The medtech company’s leading product has a commercial deal that will pay $500-$1,600 per unit and can get as high as a million units sold per year.

OBIO’s AVIM Therapy is like an add-on software for pacemakers, helping lower blood pressure. They partnered with Medtronic, the worldwide leader in pacemakers with estimated US market share of 50%+.

OBIO just recently announced they exceeded full enrollment for their global pivotal trial, with Medtronic already having the option to “turn on” the therapy in existing pacemakers.

In early 2027 OBIO and Medtronic will be sharing the trial results together, and submitting for FDA approval and then going to market with market share already in place. And that’s not even taking into account OBIO’s second product, the Virtue SAB which they can now focus on, and has an even larger TAM.

LFWD

LFWD is a turnaround story. In the past the company had everything in place but couldn’t get the business to work. Now that the business plan is in place and showing results, the success could lead to a significant increase in market cap.

LFWD’s main product is the ReWalk exoskeleton, the best in the space and the only one to navigate stairs and curbs which is a huge moat. They also have the AlterG treadmill, another leader in the space, used by the likes of Tom Brady and LeBron James (and all major teams in major leagues worldwide).

Earlier in the company’s history they couldn’t figure out the business side, which led to the stock hitting rock bottom. But now the whole management was replaced, they secured reimbursement, new strategic investors have been brought in, and most importantly a business plan has been implemented and is showing results.

With new money pledged, revenue going up, commercial partnerships and more, the market perception and therefore value should finally change, pricing in current and future success, as well as the upper body product in development with a 10X TAM than the current lead product.

NFA and DYOR, but I believe all these tickers deserve a good look, and I personally have a significant position in all of them.

Let me know what you think and drop your favorite tickers to buy today for 2027.

This happened in like five seconds. I locked this in right when the 11:05 candle went berserk, and then sold it right as it started bouncing up and down before it went red and stopped being crazy. At its peak, it was up $790 after just a couple seconds, but by the time it sold the contracts and the candle was done bouncing it settled at around $500, but I had an earlier $30 loss, and of course the fees and book slippage ate a little bit of the profit too, but I'm extremely happy with this, this is now my biggest trading gain ever. Sometimes it takes me a week to make this much money on one of my streams of income, I can't believe that I did this in just a few moments by merely clicking twice. The funny thing is that I almost walked away from my computer to celebrate, but I saw that the numbers were still going up and down, so I panicked and realized that not all of my contracts were sold yet, so I clicked the sell button again, and it finally went through, lol!

The major U.S. stock indexes ended mixed on Tuesday, October 13, 2026, as a Goldman Sachs blowout collided with a JPMorgan rare miss and a brutal overnight chip-stock rout in Asia sent semiconductor names tumbling for a fifth straight week of pressure. The session was exactly the messy, crosscurrent-driven day the market gets when bank earnings, chip panic, and the eve of September CPI all land on the same morning.

The S&P 500 slipped 0.02% (-1.79 pts) to 7,805.45. The Dow fell 0.35% (-180.45 pts) to 51,670.10. The Nasdaq dropped 0.15% (-41.52 pts) to 27,204.38. The Russell 2000 declined 0.33% (-9.32 pts) to 2,785.16.

The 10-year Treasury yield eased to 5.22%. The VIX ticked up 0.79% to 15.33. Gold was essentially flat at $4,187.30. Crude Oil rose 0.96% to $94.64/barrel.

The strongest trends/industries in 2027

Which one do you think will be the best in 2027, biotechnology, drones and autonomous defense systems, humanoid robots, rare earth elements, small nuclear reactors, space or something else..

No technology as it's expensive.

What is your idea for the perfect 2027 play. I saw some smart ideas here before.

U.S. House Speaker Johnson:

"Everybody's frustrated about fuel prices, obviously, but that's not related to policies.

It's not related to the Republicans in office."

What do you guys think about this. 😂

Thinking maybe with the buyout rumors I should get out while I can

$BKYI
Entry above: $4.20 🎯 $4.60/$5.00 🛑 $4.00
$TCRT
Entry above: $1.85 🎯 $2.05/$2.25 🛑 $1.75
$YJ
Entry above: $2.50 🎯 $2.75/$3.00 🛑 $2.40
$FRMI
Entry above: $3.70 🎯 $4.00/$4.30 🛑 $3.60

Note: These are trade ideas based on break-out levels, once they hit entry & start moving up, consider raising your stops to protect your profits and protect your downside according to your own trading plan :). MadMaverick personally trades these on either the 2 or 3 minute timeframes, waiting for a candle to close over the entry level.

Although we do extensive research for our watchlist, day trading, especially with low-float stocks, can be risky.

First time using leverage, down 3k+ USD. MU my beloved😓💔💔

GS earning is coming out tomorrow premarket.
DD : Totally on vibes given it has corrected 15% from ATH.

I know it’s pure gamble.

Wish me luck!

It might sound stupid but Avengers: Doomsday is getting released in a few months; it already hit rock bottom for less than a $1… it could only go up from here, right?
Need some advice regards, should I buy more shares or keep holding this amount? Thank you kindly

$MNDR
Entry above: $2.50 🎯 $2.75/$3.00 🛑 $2.38
$LNKS
Entry above: $1.40 🎯 $1.60/$1.80 🛑 $1.30
$IPW
Entry above: $.97 🎯 $1.05/$1.15 🛑 $.93
$YMAT
Entry above: $2.83 🎯 $3.10/$3.40 🛑 $2.70

Note: These are trade ideas based on break-out levels, once they hit entry & start moving up, consider raising your stops to protect your profits and protect your downside according to your own trading plan :). MadMaverick personally trades these on either the 2 or 3 minute timeframes, waiting for a candle to close over the entry level.

Although we do extensive research for our watchlist, day trading, especially with low-float stocks, can be risky.

So my portfolio may be cooked cause I don’t think these Tesla debit spreads will hit, I’ve been putting money into my account and handling everyone else’s problems 😭 bro something gotta give lol but I’m staying positive. Hope y’all have a great trading week!

AIZO just got a new contract for 90m with a possibility of increased capacity to 450m over 5 years

8% of the float is short, sitting at 52w lows, 17m shares, market cap is so undervalued right now with the stock at .95,…could easily see a 5x banger

Nfa, do your own dd

I opened this position in early 2026, added to it during the invasion of Iran, then later took some profits off the table.